Biote Corp (BTMD)
5.75
-0.09
(-1.54%)
USD |
NASDAQ |
May 17, 16:00
5.86
+0.11
(+1.91%)
After-Hours: 20:00
Biote Gross Profit Margin (Quarterly): 71.44% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 71.44% |
| December 31, 2023 | 69.36% |
| September 30, 2023 | 68.90% |
| June 30, 2023 | 67.87% |
| March 31, 2023 | 69.05% |
| December 31, 2022 | 65.33% |
| Date | Value |
|---|---|
| September 30, 2022 | 68.22% |
| June 30, 2022 | 67.27% |
| March 31, 2022 | 66.95% |
| December 31, 2021 | 63.97% |
| September 30, 2021 | 65.45% |
| June 30, 2021 | 66.50% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
63.97%
Minimum
Dec 2021
71.44%
Maximum
Mar 2024
67.53%
Average
67.57%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Teladoc Health Inc | 69.89% |
| American Shared Hospital Services | 49.42% |
| Novo Integrated Sciences Inc | 41.76% |
| Astrana Health Inc | 18.29% |
| Cryo-Cell International Inc | 72.49% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | 5.57% |
| Return on Invested Capital | 14.30% |
| Profit Margin (Quarterly) | -4.42% |
| Operating Margin (Quarterly) | 22.28% |
| Return on Net Operating Assets | 14.09% |